Megan Robertson, Associate in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, authored an article in Cannabis Business Executive, titled “CBD DD: Key Considerations When Conducting Due Diligence on Cannabis Companies.”

Following is an excerpt:

While the regulatory atmosphere surrounding cannabis and cannabis-related products is still in flux, private equity and other investors have begun to consider the potential for transactions in the industry. This article explores the key due diligence and regulatory compliance considerations that both buyers and sellers should be aware of in the event of a potential deal involving the manufacture and/or sale of cannabis products, such as hemp and cannabidiol (“CBD”). …

Clearly Defined Product Lines

In the cannabis industry, a company must maintain well-defined product lines. The terms cannabis, hemp, CBD, and others are used rather loosely, despite the fact that they are distinct and regulated differently. …

Due to the intricate distinctions identified above, and with the understanding that the regulatory landscape surrounding cannabis and cannabis-derived products is under development, it is crucial for companies to be transparent about their products and the specific ingredients that they contain. During a public FDA hearing over the summer of 2019, various consumer advocates testified that, based on laboratory analyses of popular commercially-available CBD-containing products, most do not contain the exact ingredients or concentration of key compounds (i.e., CBD versus THC) disclosed on the label. False and/or misleading labeling can lead to enforcement action by both FDA and the Federal Trade Commission (“FTC”).

Therefore, potential buyers or investors conducting diligence on cannabis companies should request that the target company produce certificates of analysis supporting the composition of their products, and should also consider conducting independent analyses to confirm the company’s findings. It is also critical to evaluate the target entity’s manufacturing practices to ensure that quality control systems are robust and capable of ensuring consistency across batches and product lines.

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.